Testing effectiveness (Phase 2)Study completedNCT00787527What this trial is testingSAHA + CHOP in Untreated T-cell Non-Hodgkin's LymphomaWho this might be right forLymphoma M.D. Anderson Cancer Center 14
Early research (Phase 1)Study completedNCT03049449What this trial is testingT Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing LymphomasWho this might be right forLymphoma, Large-Cell, AnaplasticEnteropathy-Associated T-Cell LymphomaLymphoma, Large B-Cell, Diffuse+2 more National Cancer Institute (NCI) 26
Early research (Phase 1)Ended earlyNCT01769222What this trial is testingIpilimumab and Local Radiation for Selected Solid TumorsWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more Stanford University 3
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Not applicableStudy completedNCT02551289What this trial is testingMAgnetic Resonance Imaging in COeliac DiseaseWho this might be right forCeliac DiseaseCoeliac DiseaseCeliac Sprue+1 more University of Nottingham 72
Early research (Phase 1)UnknownNCT04480788What this trial is testingCD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label StudyWho this might be right forT Lymphoblastic Leukemia/LymphomaExtramedullary NK-T-cell Lymphoma, Nasal TypePeripheral T-cell Lymphoma, Nonspecific+4 more PersonGen BioTherapeutics (Suzhou) Co., Ltd. 9
Early research (Phase 1)Study completedNCT00073944What this trial is testingBCX-1777 in Treating Patients With Refractory CancerWho this might be right forCancer BioCryst Pharmaceuticals
Early research (Phase 1)Study completedNCT01158274What this trial is testingRO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAIDS-related Diffuse Large Cell Lymphoma+83 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT02588651What this trial is testingA Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL)Who this might be right forT-cell LymphomaAngioimmunoblastic T-cell LymphomaHepato-splenic T-cell Lymphoma+3 more Deepa Jagadeesh 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT03598998What this trial is testingPembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell LymphomasWho this might be right forAnaplastic Large Cell LymphomaNodal Peripheral T-Cell Lymphoma With TFH PhenotypeRecurrent Anaplastic Large Cell Lymphoma+17 more City of Hope Medical Center 13
Early research (Phase 1)Study completedNCT00697346What this trial is testingStudy of MLN8237 in Participants With Advanced Hematological MalignanciesWho this might be right forB-cell Follicular LymphomaB-cell Marginal Zone LymphomaDiffuse Large B-cell Lymphoma+10 more Millennium Pharmaceuticals, Inc. 58
Early research (Phase 1)Temporarily pausedNCT05377827What this trial is testingDose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic MalignanciesWho this might be right forT-Cell Non-Hodgkin LymphomaAcute Myeloid LeukemiaAngioimmunoblastic T-cell Lymphoma+12 more Washington University School of Medicine 6
Testing effectiveness (Phase 2)Study completedNCT02561273What this trial is testingCombination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's LymphomaWho this might be right forAnaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveHepatosplenic T-Cell Lymphoma+7 more University of Nebraska 54
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Not applicableUnknownNCT03095573What this trial is testingComparison Between Axial- and Lateral-viewing Capsule Endoscopy in Celiac DiseaseWho this might be right forCeliac Disease Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 25
Not applicableStudy completedNCT02652715What this trial is testingSalvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-Cell LymphomaAdult T-Cell Leukemia/LymphomaAnaplastic Large Cell Lymphoma+29 more Mayo Clinic 29
Testing effectiveness (Phase 2)Ended earlyNCT03075553What this trial is testingNivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell LymphomaWho this might be right forBlastic Plasmacytoid Dendritic Cell NeoplasmHepatosplenic T-Cell LymphomaHTLV-1 Infection+14 more Mayo Clinic 12
Testing effectiveness (Phase 2)Ended earlyNCT00810576What this trial is testingCombination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's LymphomaWho this might be right forLymphoma M.D. Anderson Cancer Center 1
Not applicableLooking for participantsNCT05978141What this trial is testingA Registry for People With T-cell LymphomaWho this might be right forT-cell LymphomaNK-Cell LymphomaT-cell Prolymphocytic Leukemia+28 more Memorial Sloan Kettering Cancer Center 1,000
Early research (Phase 1)Study completedNCT00036790What this trial is testingMotexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more University of Wisconsin, Madison